Mounting Evidence Supporting Neoadjuvant ChemoIO Means Surgeons Must Adapt

More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

European Commission OKs Tislelizumab for NSCLC

In Case You Missed It: Recent News from IASLC

LAURA Trial Defines Role of EGFR-directed Therapy in Unresectable Stage III NSCLC

ADRIATIC Demonstrates Meaningful Improvements in OS, PFS in Patients with Limited-stage SCLC

Patient Perspective: Exercise Prescriptions Needed for Lung Cancer Patients

Glecirasib Shows Promise in Treating Advanced Lung Cancer Harboring KRAS G12C Mutations

US FDA Grants Accelerated Approval to Tarlatamab-dlle for Extensive-stage Small Cell Lung Cancer

CROWN Results Demonstrate Longest Progression-Free Survival in Advanced NSCLC Seen to Date